Navegando por Palavras-chave "Proteína axina"

Agora exibindo 1 - 1 de 1
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    O complexo destruidor de betacatenina no carcinoma colorretal e no adenoma cólico
    (Inst Israelita Ensino & Pesquisa Albert Einstein, 2016) Bourroul, Guilherme Muniz; Fragoso, Helio Jose; Gomes, Jose Walter Feitosa; Bourroul, Vivian Sati Oba; Oshima, Celina Tizuko Fujiyama [UNIFESP]; Gomes, Thiago Simao [UNIFESP]; Saba, Gabriela Tognini; Palma, Rogerio Tadeu; Waisberg, Jaques [UNIFESP]
    Objective: To evaluate the destruction complex of beta-catenin by the expression of the proteins beta-catetenin, adenomatous polyposis coli, GSK3 beta, axin and ubiquitin in colorectal carcinoma and colonic adenoma. Methods: Tissue samples from 64 patients with colorectal carcinoma and 53 patients with colonic adenoma were analyzed. Tissue microarray blocks and slides were prepared and subjected to immunohistochemistry with polyclonal antibodies in carcinoma, adjacent non-neoplastic mucosa, and adenoma tissues. The immunoreactivity was evaluated by the percentage of positive stained cells and by the intensity assessed through of the stained grade of proteins in the cytoplasm and nucleus of cells. In the statistical analysis, the Spearman correlation coefficient, Student's t, chi(2), Mann-Whitney, and McNemar tests, and univariate logistic regression analysis were used. Results: In colorectal carcinoma, the expressions of beta-catenin and adenomatous polyposis coli proteins were significantly higher than in colonic adenomas (p<0.001 and p<0.0001, respectively). The immunoreactivity of GSK3 beta, axin 1 and ubiquitin proteins was significantly higher (p=0.03, p=0.039 and p=0.03, respectively) in colorectal carcinoma than in the colonic adenoma and adjacent non-neoplastic mucosa. The immunohistochemistry staining of these proteins did not show significant differences with the clinical and pathological characteristics of colorectal cancer and colonic adenoma. Conclusions: These results suggest that, in adenomas, the lower expression of the beta-catenin, axin 1 and GSK3 beta proteins indicated that the destruction complex of beta-catenin was maintained, while in colorectal carcinoma, the increased expression of beta-catenin, GSK3 beta, axin 1, and ubiquitin proteins indicated that the destruction complex of beta-catenin was disrupted.